India’s medical device import framework has shifted significantly in 2026 under the Central Drugs Standard Control Organisation (CDSCO). The transition from voluntary to mandatory compliance is finalized, and stricter oversight has been implemented across the board.
The primary updates shaping medical device imports in 2026 highlight the core changes foreign manufacturers and Indian importers must adapt to:
1. End of Voluntary Registration & Universal Licensing
The transitional voluntary registration framework has fully concluded. Every medical device imported into India must now be strictly categorized under the risk-based structure (Class A to D) defined by the Medical Devices Rules (MDR), 2017.
- Class A & B: Low to Low-Moderate Risk. (Note: Class A non-sterile/non-measuring devices utilize a self-certification route, but all others require full licensing).
- Class C & D: Moderate-High to High Risk.
- Mandatory Gateway: Except for exempted low-risk items, no commercial medical device can legally clear customs without a formal Form MD-15 Import License.
2. The Direct Import Proposal for Hospitals (Draft Amendments)
In a major policy push introduced mid-2026 (via Draft Amendments like G.S.R. 515(E)), the government is planning a pathway to allow hospitals to directly import a specific list of roughly 80 high-end medical devices (such as advanced MRI and CT scanners).
- The Goal: Bypas the traditional, multi-layered distributor route to fast-track advanced tech directly to healthcare facilities.
- The Caveat: Domestic industry groups have raised significant warnings regarding how patient safety, maintenance, and post-market tracking will be managed if traditional importers are cut out of the loop.
3. Mandatory Indian Authorized Agent (IAA)
Foreign manufacturers cannot directly log into the CDSCO’s digital portal or hold an import license themselves. You must appoint a local, legally recognized Indian Authorized Agent (IAA) who holds a valid wholesale license. The IAA acts as your legal proxy, submits the Form MD-14 application via the online SUGAM platform, handles technical queries, and coordinates vigilance reporting.
4. Enhanced Traceability & Labeling Rules
Labeling compliance is being audited far more aggressively. Device labels must provide unmistakable clarity, explicitly detailing the manufacturer, importer info, license number, manufacturing/expiry dates, and exact usage warnings. Furthermore, the integration of digital tracking mechanisms like QR codes is heavily emphasized to ensure step-by-step traceability across the supply chain.
5. Elimination of the Sterilization Loan License
On a positive note for streamlined operations, CDSCO updated rules to state that companies outsourcing their product sterilization to a third party no longer need to apply for an independent “Loan License” (Form MD-6/MD-8), provided the sterilization facility they are partnering with is already formally licensed by the CDSCO. This cuts redundant administrative steps and saves costs while keeping strict quality controls intact.
What to Prepare in the Technical Dossier
When filing Form MD-14 via the SUGAM portal, the CDSCO requires strict “Fourth Schedule” alignment:
- Plant Master File (PMF) & Device Master File (DMF): Covering design validation, risk management, and facility layout.
- Free Sale Certificate (FSC): Proving the device is legally sold in its country of origin. For Class C and D devices, if you don’t have an FSC from recognized regions (like the US, EU, Canada, Australia, or Japan), CDSCO will likely mandate local clinical trials in India before approval.
- Vigilance Plan: Active adherence to the Materiovigilance Programme of India (MvPI), outlining how you will track and report adverse events.
Crucial Tip for 2026: CDSCO has accelerated the disposal and rejection of long-pending applications on the SUGAM portal where importers have left regulatory queries unanswered. Responding quickly and precisely to deficiency letters is mandatory to keep your application from being outright dismissed.
Ready to Navigate India’s Updated CDSCO Framework?
The 2026 CDSCO regulations leave no room for compliance delays. Whether you are an international manufacturer looking to enter the Indian market under the new rules or a local importer adjusting to the mandatory Form MD-15 licensing and traceability requirements, immediate regulatory alignment is critical to prevent customs hold-ups.
Avoid application rejections on the SUGAM portal. Get expert guidance to secure your Indian Authorized Agent (IAA) representation, compile your Technical Dossiers, and streamline your import pipeline today.
Import Medical Devices: Contact Us Now
Ensure seamless customs clearance and total regulatory compliance for your medical devices.
Manufacturers: Connect Directly with Our Experts
Are you an international manufacturer needing immediate assistance with Form MD-14 filings or navigating the new direct-to-hospital import proposals? Speak directly to our lead regulatory consultant:
💬 WhatsApp: Chat with Us on WhatsApp
📞 Call Us: +91 8920964801